TY - JOUR
T1 - Affinity Maturation of Macrocyclic Peptide Modulators of Lys48-Linked Diubiquitin by a Twofold Strategy
AU - Huang, Yichao
AU - Nawatha, Mickal
AU - Livneh, Ido
AU - Rogers, Joseph M.
AU - Sun, Hao
AU - Singh, Sumeet K.
AU - Ciechanover, Aaron
AU - Brik, Ashraf
AU - Suga, Hiroaki
N1 - Funding Information:
The authors thank Dr. Masanobu Nagano and Dr. Hayden Peacock for helpful discussions and manuscript critique. This work was supported by the Japan Agency for Medical Research and Development (AMED), Basic Science and Platform Technology Program for Innovative Biological Medicine under JP19am0301001, and Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) under JP19am0101090 to H.S., and by the Dr. Miriam and Sheldon Adelson Medical Research Foundation (AMRF), the Israel Science Foundation (ISF), the German‐Israeli Foundation for Research and Development (GIF) and a Professorship funded by the Israel Cancer Research Fund (ICRF) to A.B.
Publisher Copyright:
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2020/6/26
Y1 - 2020/6/26
N2 - Messenger RNA display of peptides containing non-proteinogenic amino acids, referred to as RaPID system, has become one of the leading methods to express libraries consisting of more than trillion-members of macrocyclic peptides, which allows for discovering de novo bioactive ligands. Ideal macrocyclic peptides should have dissociation constants (KD) as low as single-digit values in the nanomolar range towards a specific target of interest. Here, a twofold strategy to discover optimized macrocyclic peptides within this affinity regime is described. First, benzyl thioether cyclized peptide libraries were explored to identify tight binding hits. To obtain more insights into critical sequence information, sequence alignment was applied to guide rational mutagenesis for the improvement of their binding affinity. Using this twofold strategy, benzyl thioether macrocyclic peptide binders against Lys48-linked ubiquitin dimer (K48-Ub2) were successfully obtained that display KD values in the range 0.3–1.2 nm, which indicate binding two orders of magnitude stronger than those of macrocyclic peptides recently reported. Most importantly, this macrocyclic peptide also showed an improved cellular inhibition of the K48-Ub2 recognition by deubiquitinating enzymes and the 26S proteasome, resulting in the promotion of apoptosis in cancer cells.
AB - Messenger RNA display of peptides containing non-proteinogenic amino acids, referred to as RaPID system, has become one of the leading methods to express libraries consisting of more than trillion-members of macrocyclic peptides, which allows for discovering de novo bioactive ligands. Ideal macrocyclic peptides should have dissociation constants (KD) as low as single-digit values in the nanomolar range towards a specific target of interest. Here, a twofold strategy to discover optimized macrocyclic peptides within this affinity regime is described. First, benzyl thioether cyclized peptide libraries were explored to identify tight binding hits. To obtain more insights into critical sequence information, sequence alignment was applied to guide rational mutagenesis for the improvement of their binding affinity. Using this twofold strategy, benzyl thioether macrocyclic peptide binders against Lys48-linked ubiquitin dimer (K48-Ub2) were successfully obtained that display KD values in the range 0.3–1.2 nm, which indicate binding two orders of magnitude stronger than those of macrocyclic peptides recently reported. Most importantly, this macrocyclic peptide also showed an improved cellular inhibition of the K48-Ub2 recognition by deubiquitinating enzymes and the 26S proteasome, resulting in the promotion of apoptosis in cancer cells.
KW - RaPID system
KW - diubiquitin
KW - macrocyclic peptides
KW - messenger RNA display
KW - proteasome
UR - http://www.scopus.com/inward/record.url?scp=85086170499&partnerID=8YFLogxK
U2 - 10.1002/chem.202000273
DO - 10.1002/chem.202000273
M3 - Article
C2 - 32105365
AN - SCOPUS:85086170499
SN - 0947-6539
VL - 26
SP - 8022
EP - 8027
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
IS - 36
ER -